Benefit-risk balance of COVID drugs. New prospects

Detalles Bibliográficos
Autores principales: Cracowski, Jean-Luc, Richard, Vincent, Molimard, Mathieu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. 2022
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444335/
https://www.ncbi.nlm.nih.gov/pubmed/36100496
http://dx.doi.org/10.1016/j.therap.2022.09.001
_version_ 1784783194098237440
author Cracowski, Jean-Luc
Richard, Vincent
Molimard, Mathieu
author_facet Cracowski, Jean-Luc
Richard, Vincent
Molimard, Mathieu
author_sort Cracowski, Jean-Luc
collection PubMed
description
format Online
Article
Text
id pubmed-9444335
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-94443352022-09-06 Benefit-risk balance of COVID drugs. New prospects Cracowski, Jean-Luc Richard, Vincent Molimard, Mathieu Therapie Editorial Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. 2022 2022-09-06 /pmc/articles/PMC9444335/ /pubmed/36100496 http://dx.doi.org/10.1016/j.therap.2022.09.001 Text en © 2022 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Editorial
Cracowski, Jean-Luc
Richard, Vincent
Molimard, Mathieu
Benefit-risk balance of COVID drugs. New prospects
title Benefit-risk balance of COVID drugs. New prospects
title_full Benefit-risk balance of COVID drugs. New prospects
title_fullStr Benefit-risk balance of COVID drugs. New prospects
title_full_unstemmed Benefit-risk balance of COVID drugs. New prospects
title_short Benefit-risk balance of COVID drugs. New prospects
title_sort benefit-risk balance of covid drugs. new prospects
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444335/
https://www.ncbi.nlm.nih.gov/pubmed/36100496
http://dx.doi.org/10.1016/j.therap.2022.09.001
work_keys_str_mv AT cracowskijeanluc benefitriskbalanceofcoviddrugsnewprospects
AT richardvincent benefitriskbalanceofcoviddrugsnewprospects
AT molimardmathieu benefitriskbalanceofcoviddrugsnewprospects

Ejemplares similares